CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung Cancer.
Xuehan ChenYanzhuo LiuYang WangChenlong WangXuewei ChenYu XiongLilong LiuXi YuanHonglin TangChong ShuJing ZhangAustin M GuoHonglei ChenJing YangPublished in: Cancer research (2022)
The identification of a role for CYP4F2-dependent metabolism in driving immune evasion in non-small cell lung cancer reveals a strategy to improve the efficacy of immunotherapy by inhibiting CYP4F2. See related article by Van Ginderachter, p. 3882.